The MILESTONE Study: Improving Transition From Child to Adult Mental

Status Active, not recruiting

Clinical Trial Summary

This study evaluates the longitudinal health and social outcomes of adolescent mental health service users who are at the transition boundary of their child and adolescent mental health service, and whether the implementation of a model of managed transition at the service boundary benefits them, as compared to usual care.

Clinical Trial Description

The MILESTONE study focuses on the period when young people attending a children and adolescents mental health service (CAMHS) need to move on, or "transition", to an adult mental health service (AMHS), if they still require care or treatment. We know from other research that this transition is not always properly managed and that improving the transition process can have a positive impact on the health and well-being of young people in this position. We want to evaluate what impact the different transition experiences have on young people's health and well-being, and whether the process of Managed Transition has any benefits as compared to usual care.

The MILESTONE study is run in eight European countries (UK, Ireland, Belgium, Holland, France, Germany, Italy and Croatia). CAMHS in the study regions are selected to provide the young people in their care that are reaching transition age either usual care or a novel service called "Managed Transition", which includes the use of a new decision support tool, the Transition Readiness and Appropriateness Measure (TRAM). This should help with decision making and enable better transitions by identifying cases for whom transition from CAMHS to AMHS is advisable and appropriate, or who can be safely discharged or referred to a community based service. CAMHS are randomly assigned to provide the intervention of Managed Transition or usual care. The health and well-being of the young people attending these services is assessed at the start of the study and then followed-up for 24 months to see whether they transition to AMHS or are discharged or referred to some other service. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03013595
Study type	Interventional
Source	University of Warwick
Contact
Status	Active, not recruiting
Phase	N/A
Start date	October 2015
Completion date	December 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05639855` - Study on Mental Health-related Stigma	N/A
Completed	`NCT03042832` - Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention	N/A
Completed	`NCT03007940` - Using NIATx Strategies to Implement Integrated Services in Routine Care	N/A
Active, not recruiting	`NCT05726617` - Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health Disorders	N/A
Active, not recruiting	`NCT04090723` - Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum	N/A
Enrolling by invitation	`NCT05523843` - Pilot Study on the Clinical Utility of the Tulsa Life Chart
Recruiting	`NCT04299789` - Military Service Identification Tool
Recruiting	`NCT05258578` - Tele-BARICARE to Manage COVID-19-Related Distress	N/A
Recruiting	`NCT06190184` - Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions	N/A
Completed	`NCT04649736` - Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients	N/A
Not yet recruiting	`NCT05097807` - The Impact of Shallow Reading in Social Media	N/A
Active, not recruiting	`NCT05092542` - Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers	N/A
Completed	`NCT05274958` - Effectiveness of Telepsychiatry With Randomized Waitlist Control Utilizing Patient Reported Outcome Measures	N/A
Completed	`NCT05303870` - Impact of Psychological Therapies on Emergency Medical Patients	N/A
Recruiting	`NCT04841655` - Tobacco Cessation Among Smokers Under Alcohol and/or Cannabis Treatment
Completed	`NCT05213182` - Peer Support Intervention to Mitigate Social Isolation and Stigma of Adolescent Motherhood in Zimbabwe	Phase 2
Completed	`NCT05638516` - Improving Mental Health in Youth and Lowering Risk for Obesity Through a Digital Preventative Product	N/A
Completed	`NCT06311084` - IMAGINATOR 2.0: Co-design and Early Evaluation of a Novel Blended Digital Intervention Targeting Self-harm in Young People	N/A
Active, not recruiting	`NCT04600414` - Collaborating to Heal Addiction and Mental Health in Primary Care	N/A
Completed	`NCT03770221` - Coordinating Access to Care for People Experiencing Homelessness (CATCH-FI)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The MILESTONE Study: Improving Transition From Child to Adult Mental Health Care — MILESTONE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms